Velocity is the world's leading integrated site organization.
Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.
Simplify everything from site selection to study close-out
Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.
News
Velocity Has Supported Research for 12 Products That Have Received FDA Approval in 2024
Velocity sites and investigators have now supported research for 12 products that received U.S. FDA approval in 2024! This year’s groundbreaking approvals include: Ebglyss (lebrikizumab-lbkz) by Eli Lilly, a new … Read more
Raghu Punnamraju, CTO, for VentureBeat: Why data science alone won’t make your product successful
In this new article for VentureBeat, Raghu Punnamraju, Chief Technology Officer at Velocity, discusses why data science alone is not enough to ensure product success. In this insightful piece, Raghu … Read more
Paul Evans Featured in Business North Carolina Article on AI in the State’s Clinical Research Industry
Paul Evans was recently featured in a Business North Carolina article discussing the emerging impact of artificial intelligence on North Carolina’s clinical research industry. As Paul notes, “Our industry is … Read more
Drs. Essink and Overcash Author Article Featured in Nature Communications for Moderna COVE Study
Brandon Essink, MD, CPI, and J. Scott Overcash, MD, were authors of a recent Nature Communications article, “Long-term safety and effectiveness of mRNA-1273 vaccine in adults: COVE trial open-label and … Read more